Showing results (11-20 of 3,366) with videos related to

Sort By:
Pageof 337
Bone Marrow Transplantation|December 1, 1989
Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 yearsT De Witte, P Muus, B De Pauw, et al.
Scandinavian Journal of Haematology|November 1, 1985
Repetitive cycles of cytoreductive therapy followed by stem cell autografting for nonlymphoblastic transformation of chronic granulocytic leukaemiaT de Witte, R Raymakers, B de Pauw, et al.
Cancer|September 1, 1990
Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemiaT De Witte, P Muus, B De Pauw, et al.
Blut|May 1, 1988
Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter studyM Werter, R de Witte, J Janssen, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 11, 1987
Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantationT de Witte, I Novakova, J Branolte, et al.
Veterinary Journal (London, England : 1997)|February 16, 2016
Topography and ultrasonographic identification of the equine pulmonary vein draining patternT Vandecasteele, G van Loon, K Vandevelde, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosisM Ellis, D Spence, B de Pauw, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of cytarabine in Hodgkin's disease. The EORTC Lymphoma Cooperative GroupJ Thomas, B de Pauw, A Hagenbeek, et al.
Cancer|February 1, 1980
High spontaneous thymidine incorporation into a non-T lymphocyte population in Hodgkin's disease unmasked after cell fractionationB de Pauw, D J Theo Wagener, J Smeulders, et al.
Pageof 337